Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19
Erin K McCreary(University of Pittsburgh Medical Center), Kevin E. Kip(UPMC Health System), Anna Nakayama, Graham M. Snyder(University of Pittsburgh), Oscar C. Marroquin(University of Pittsburgh), Scott Berry(Queen's University), Amy Crawford(Berry & Associates (United States)), Russell Meyers(University of Pittsburgh), Christopher Seymour(University of Pittsburgh), Michelle Adam(University of Pittsburgh), David T. Huang(University of Pittsburgh), Paula L. Kip(University of Pittsburgh Medical Center), Tami Minnier(University of Pittsburgh Medical Center), Judith A. Shovel(University of Pittsburgh Medical Center), William Garrard(UPMC Health System), J Ryan Bariola(University of Pittsburgh), Debbie Albin(UPMC Health System), Anna McGlothlin(Berry & Associates (United States)), Mary Kay Wisniewski(University of Pittsburgh Medical Center), Mark Schmidhofer(University of Pittsburgh), Lindsay R. Berry(Berry & Associates (United States)), Stephanie K. Montgomery(University of Pittsburgh), Kelsey Linstrum(University of Pittsburgh), Donald M. Yealy(University of Pittsburgh), Derek C. Angus(University of Pittsburgh), Kevin Collins(UPMC Health System), Richard J. Wadas(University of Pittsburgh)
Cited by 36
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k